First in China! Wanbang Biopharma Perphenazine Tablets Pass Generics Consistency evalsuation
Recently, Shanghai Zhaohui Pharmaceutical Co., Ltd. ("Zhaohui Pharmaceutical"), a member enterprise of Jiangsu Wanbang Biopharmaceuticals Co., Ltd. ("Wanbang Biopharma"), received the Notice on Approval of Supplementary Drug Application for Perphenazine Tablets (2 mg, 4 mg) (No.: 2020B04654, 2020B04655) from NMPA. The drug is the first of its kind in China to pass the consistency evalsuation of quality and efficacy of generic drugs.
Perphenazine Tablets has successfully passed the generics consistency evalsuation, which will help improve the product's competitiveness, enhance the product's market position and bring new market opportunities.